Skip to content

Daytime Profile of Salivary Progesterone

Daytime Profile of Salivary Progesterone During the Mid-luteal Phase of IVF and FET Cycles

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03725904
Enrollment
20
Registered
2018-10-31
Start date
2018-10-24
Completion date
2020-01-01
Last updated
2020-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Female

Keywords

Progesterone, Saliva, IVF, Frozen embryo transfer

Brief summary

The aim of this study is to perform a 12-hour profile of free saliva progesterone during the luteal phase after fresh and frozen embryo transfer. If progesterone levels in saliva samples show a constant level during daytime, this non-invasive measurement can be used in future ART patients with insufficient progesterone levels who might benefit from additional exogenous progesterone supplementation.

Interventions

DIAGNOSTIC_TESTProgesterone analysis in saliva

Analysis of salava progesterone

Sponsors

Boston IVF
CollaboratorOTHER
Peter Humaidan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-45 years * One or two good quality embryos for transfer on day 5. * BMI \>18,5 \<30 kg/m²

Exclusion criteria

* No good quality embryos for transfer * Uterine abnormalities * One ovary * Oocyte donation

Design outcomes

Primary

MeasureTime frame
Levels of free progesterone in saliva12 hours

Secondary

MeasureTime frameDescription
Clinical pregnancy rate8 weeksUltrasound detected gestational sack divided with number of embryo transfer
Ongoing pregnancy rate12 weeksViable pregnancy after gestational week 12+0

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026